Meetgyl-DG Dental Gel is a topical formulation combining Lidocaine (2% w/w), Chlorhexidine Gluconate (1% w/w), and Metronidazole (1% w/w) designed for the management of oral infections and associated pain. Lidocaine acts as a local anesthetic, providing rapid and effective analgesia by blocking nerve signal transmission, thereby alleviating discomfort during dental procedures or in cases of oral mucosal irritation. Chlorhexidine Gluconate serves as a broad-spectrum antimicrobial agent, exhibiting bactericidal activity against Gram-positive and Gram-negative bacteria, as well as some fungi, making it effective in reducing oral microbial load and preventing secondary infections. Metronidazole, an antiprotozoal and antibacterial agent, specifically targets anaerobic bacteria commonly implicated in periodontal infections, enhancing the gel’s efficacy in treating gingivitis, periodontitis, and other anaerobic oral infections. The synergistic combination of these active ingredients ensures comprehensive management of pain, inflammation, and microbial contamination within the oral cavity. Meetgyl-DG Dental Gel is indicated for use in dental practice for symptomatic relief and adjunctive treatment of oral infections, including mucositis, gingivitis, and periodontitis. It should be applied topically as directed by a healthcare professional, avoiding ingestion. Caution is advised in patients with known hypersensitivity to any component.